1 2 aim

Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production

Charleston JS, Schnell FJ, Dworzak J, et al. Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production. Neurology 2018;90:e2146-e2154 Twelve patients included in the placebo-controlled trial for eteplirsen*1, where followed in an open-label extension study (the patients originally receiving placebo, where as well treated with eteplirsen in the extension study). During evaluation after […]

World Duchenne
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.